Oberholzer-Gee, Felix. "Amgen Inc.'s Epogen-Commercializing the First Biotech Blockbuster Drug (TN)." Harvard Business School Teaching Note 707-542, March 2007.
For the best part of a decade, Amgen's Epogen has been the best-selling biotech drug. This situation has now changed with the appearance of two arthritis drugs—Centocor's Remicade and Immunex ...